Ling Xie - Concepedia

Author

Ling Xie

University of North Carolina at Chapel Hill ORCID

Also Known As

Chen, Xian, Gibson, Sara A., Ling Xie, Mcilwain, Sean, Whitmire, Jason K., Xie Jin Ling, Xie Ling

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill Icahn School of Medicine at Mount Sinai Institute of Biophysics

About

Ling Xie is an author at University of North Carolina at Chapel Hill specializing in medicine, natural sciences, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	599
2	Natural Sciences	7	7	540
3	Biochemistry	4	4	349
4	Biology	1	1	17
5	Biomolecular Engineering	1	1	14

Ling Xie

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Dual base editor catalyzes both cytosine and adenine base conversions in human cells Xiaohui Zhang, Biyun Zhu, Liang Chen, Nature Biotechnology Cellular EnzymologyBiochemistryAdenine Base ConversionsHuman CellsNatural Sciences	2020	287
Harnessing the E3 Ligase KEAP1 for Targeted Protein Degradation Jieli Wei, Fanye Meng, Kwang‐Su Park, Journal of the American Chemical Society Protein FunctionProtein ExpressionKeap1 LigandE3 Ligase Keap1Natural Sciences	2021	130
Identification of two novel transmembrane γ-carboxyglutamic acid proteins expressed broadly in fetal and adult tissues John D. Kulman, J. Harris, Ling Xie, Proceedings of the National Academy of Sciences	2001	111
Discovery of First-in-Class Protein Arginine Methyltransferase 5 (PRMT5) Degraders Yudao Shen, Guozhen Gao, Xufen Yu, Journal of Medicinal Chemistry	2020	89
The expressions and clinical significances of tissue and serum galectin-3 in pancreatic carcinoma Ling Xie, Wenkai Ni, Xudong Chen, Journal of Cancer Research and Clinical Oncology Tumor BiologyPancreatic CancerMedicineSerum Galectin-3Pathology	2012	77
Discovery of a First-in-Class Mitogen-Activated Protein Kinase Kinase 1/2 Degrader Jieli Wei, Jianping Hu, Li Wang, Journal of Medicinal Chemistry	2019	64
Design, Synthesis, and Evaluation of Potent, Selective, and Bioavailable AKT Kinase Degraders Xufen Yu, Jia Xu, Ling Xie, Journal of Medicinal Chemistry	2021	51
Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer Xufen Yu, Dongxu Li, Jithesh Kottur, Journal of Medicinal Chemistry	2023	47
Overexpression of <scp>DNA </scp><i>polymerase iota</i> (<scp><i>Polι</i></scp>) in esophageal squamous cell carcinoma Jundong Zhou, Shuyu Zhang, Ling Xie, Cancer Science Polymerase KappaEsophageal CancerPathologyCancer BiologyTumor Biology	2012	43
Novel Allosteric Inhibitor-Derived AKT Proteolysis Targeting Chimeras (PROTACs) Enable Potent and Selective AKT Degradation in KRAS/BRAF Mutant Cells Xufen Yu, Jia Xu, Kaitlyn M. Cahuzac, Journal of Medicinal Chemistry	2022	32

Page 1